NYSE:CAH

Cardinal Health (CAH) Stock Price, News & Analysis

$103.37
+0.54 (+0.53%)
(As of 04/23/2024 ET)
Today's Range
$101.59
$103.75
50-Day Range
$102.83
$115.62
52-Week Range
$77.56
$116.04
Volume
2.48 million shs
Average Volume
2.28 million shs
Market Capitalization
$25.14 billion
P/E Ratio
40.70
Dividend Yield
1.93%
Price Target
$103.07

Cardinal Health MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.55 Rating Score
Upside/​Downside
0.3% Downside
$103.07 Price Target
Short Interest
Healthy
3.74% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-2.65
Upright™ Environmental Score
News Sentiment
0.72mentions of Cardinal Health in the last 14 days
Based on 33 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
10.44%
From $7.28 to $8.04 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.30 out of 5 stars

Medical Sector

121st out of 910 stocks

Drugs, Proprietaries, & Sundries Industry

3rd out of 6 stocks

CAH stock logo

About Cardinal Health Stock (NYSE:CAH)

Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

CAH Stock Price History

CAH Stock News Headlines

Exposed: 10 CENT Crypto to Explode April 20th?
Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than Bitcoin
The Top 3 Healthcare Stocks to Buy in April 2024
Exposed: 10 CENT Crypto to Explode April 20th?
Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than Bitcoin
Cardinal Health: Solid Business But Overvalued
See More Headlines
Receive CAH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cardinal Health and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/01/2024
Ex-Dividend for 4/15 Dividend
3/28/2024
Dividend Payable
4/15/2024
Today
4/23/2024
Next Earnings (Confirmed)
5/02/2024
Fiscal Year End
6/30/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Drugs, proprietaries, & sundries
Sub-Industry
Health Care Distributors
CUSIP
14149Y10
Employees
48,000
Year Founded
1971

Price Target and Rating

Average Stock Price Target
$103.07
High Stock Price Target
$125.00
Low Stock Price Target
$90.00
Potential Upside/Downside
+0.2%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.55
Research Coverage
11 Analysts

Profitability

Net Income
$261 million
Pretax Margin
0.52%

Debt

Sales & Book Value

Annual Sales
$205.01 billion
Cash Flow
$8.25 per share
Book Value
($11.20) per share

Miscellaneous

Free Float
242,868,000
Market Cap
$25.02 billion
Optionable
Optionable
Beta
0.68

Social Links

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Should I Buy Cardinal Health Stock? CAH Pros and Cons Explained

Pros

Here are some ways that investors could benefit from investing in Cardinal Health, Inc.:

  • Cardinal Health announced the location of a new pharmaceutical distribution center for over-the-counter products, indicating expansion and growth in its core pharmaceutical business.
  • The company operates in the healthcare services and products industry, providing customized solutions for various healthcare entities, which can lead to stable revenue streams.
  • Cardinal Health's diversified segments, Pharmaceutical and Medical, offer a wide range of products and services, reducing dependency on a single market.
  • Recent developments such as the construction of a new logistics center in Central Ohio demonstrate Cardinal Health's commitment to enhancing its distribution capabilities and efficiency.
  • Investors may find the current stock price of Cardinal Health (NYSE: CAH) attractive for potential value investing opportunities.

Cons

Investors should be bearish about investing in Cardinal Health, Inc. for these reasons:

  • Fluctuations in the healthcare industry regulations and policies can impact Cardinal Health's operations and profitability.
  • Competition within the healthcare services and products sector may pose challenges to Cardinal Health's market share and pricing strategies.
  • Economic downturns or healthcare spending cuts could affect the demand for Cardinal Health's products and services.
  • Changes in consumer preferences or advancements in healthcare technology may require Cardinal Health to adapt quickly, potentially leading to additional costs.
  • Investors should carefully monitor the company's financial performance and industry trends to make informed investment decisions.
These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Friday, April 12, 2024. Please send any questions or comments about these Cardinal Health pros and cons to contact@marketbeat.com.

CAH Stock Analysis - Frequently Asked Questions

Should I buy or sell Cardinal Health stock right now?

11 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Cardinal Health in the last year. There are currently 1 sell rating, 3 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" CAH shares.
View CAH analyst ratings
or view top-rated stocks.

What is Cardinal Health's stock price target for 2024?

11 Wall Street analysts have issued 12-month price targets for Cardinal Health's shares. Their CAH share price targets range from $90.00 to $125.00. On average, they expect the company's share price to reach $103.07 in the next year. This suggests that the stock has a possible downside of 0.3%.
View analysts price targets for CAH
or view top-rated stocks among Wall Street analysts.

How have CAH shares performed in 2024?

Cardinal Health's stock was trading at $100.80 at the beginning of 2024. Since then, CAH stock has increased by 2.5% and is now trading at $103.37.
View the best growth stocks for 2024 here
.

Are investors shorting Cardinal Health?

Cardinal Health saw a drop in short interest during the month of March. As of March 15th, there was short interest totaling 8,610,000 shares, a drop of 19.2% from the February 29th total of 10,650,000 shares. Based on an average daily trading volume, of 2,350,000 shares, the short-interest ratio is currently 3.7 days. Currently, 3.6% of the shares of the stock are sold short.
View Cardinal Health's Short Interest
.

When is Cardinal Health's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024.
View our CAH earnings forecast
.

How can I listen to Cardinal Health's earnings call?

Cardinal Health will be holding an earnings conference call on Thursday, May 2nd at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link.

How were Cardinal Health's earnings last quarter?

Cardinal Health, Inc. (NYSE:CAH) released its quarterly earnings results on Thursday, February, 1st. The company reported $1.82 earnings per share for the quarter, topping analysts' consensus estimates of $1.56 by $0.26. The firm had revenue of $57.45 billion for the quarter, compared to analyst estimates of $57.02 billion. Cardinal Health had a net margin of 0.30% and a negative trailing twelve-month return on equity of 57.44%. The company's revenue was up 11.6% on a year-over-year basis. During the same period in the prior year, the business earned $1.32 EPS.
Read the conference call transcript
.

How often does Cardinal Health pay dividends? What is the dividend yield for Cardinal Health?

Cardinal Health announced a quarterly dividend on Tuesday, February 6th. Stockholders of record on Monday, April 1st will be paid a dividend of $0.5006 per share on Monday, April 15th. This represents a $2.00 annualized dividend and a dividend yield of 1.94%. The ex-dividend date is Thursday, March 28th.
Read our dividend analysis for CAH
.

Is Cardinal Health a good dividend stock?

Cardinal Health (NYSE:CAH) pays an annual dividend of $2.00 per share and currently has a dividend yield of 1.85%. The company has been increasing its dividend for 27 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 78.74%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on earnings estimates, CAH will have a dividend payout ratio of 24.88% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for CAH.

What guidance has Cardinal Health issued on next quarter's earnings?

Cardinal Health updated its FY 2024 earnings guidance on Monday, April, 22nd. The company provided EPS guidance of 7.200-7.350 for the period, compared to the consensus earnings per share estimate of 7.290. The company issued revenue guidance of -.

What is Mike Kaufmann's approval rating as Cardinal Health's CEO?

357 employees have rated Cardinal Health Chief Executive Officer Mike Kaufmann on Glassdoor.com. Mike Kaufmann has an approval rating of 85% among the company's employees.

What other stocks do shareholders of Cardinal Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cardinal Health investors own include AbbVie (ABBV), AT&T (T), Johnson & Johnson (JNJ), CVS Health (CVS), Exxon Mobil (XOM), Pfizer (PFE), Chevron (CVX), Intel (INTC), Cisco Systems (CSCO) and PepsiCo (PEP).

Who are Cardinal Health's major shareholders?

Cardinal Health's stock is owned by a number of institutional and retail investors. Top institutional investors include Sumitomo Mitsui Trust Holdings Inc. (0.26%), International Assets Investment Management LLC (0.15%), Los Angeles Capital Management LLC (0.15%), Raymond James & Associates (0.14%), Miller Howard Investments Inc. NY (0.11%) and CHURCHILL MANAGEMENT Corp (0.10%). Insiders that own company stock include Deborah Weitzman, Jessica L Mayer, Mary C Scherer, Michelle Brennan, Ola M Snow and Stephen M Mason.
View institutional ownership trends
.

How do I buy shares of Cardinal Health?

Shares of CAH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Does Cardinal Health have any subsidiaries?
The following companies are subsidiares of Cardinal Health: A+ Secure Packaging LLC, Access Closure, Aero-Med LLC, Alaris Medical Systems, Allegiance Corporation, Allegiance Healthcare, AssuraMed, Automatic Liquid Packaging, Bergen Brunswig Corp, Bindley Western Industries, Blue Robin LLC, Boron LePore & Associates, Borschow Hospital & Medical Supplies, Cardinal Health 100 LLC, Cardinal Health 104 LP, Cardinal Health 105 LLC, Cardinal Health 107 LLC, Cardinal Health 108 LLC, Cardinal Health 110 LLC, Cardinal Health 112 LLC, Cardinal Health 113 LLC, Cardinal Health 114 Inc., Cardinal Health 115 LLC, Cardinal Health 116 LLC, Cardinal Health 118 LLC, Cardinal Health 119 LLC, Cardinal Health 121 LLC, Cardinal Health 122 LLC, Cardinal Health 123 LLC, Cardinal Health 124 LLC, Cardinal Health 126 LLC, Cardinal Health 127 Inc., Cardinal Health 132 LLC, Cardinal Health 2 LLC, Cardinal Health 200 LLC, Cardinal Health 201 LLC, Cardinal Health 222 (Thailand) Ltd., Cardinal Health 247 Inc., Cardinal Health 249 LLC, Cardinal Health 3 LLC, Cardinal Health 414 LLC, Cardinal Health 5 LLC, Cardinal Health 6 Inc., Cardinal Health 7 LLC, Cardinal Health Australia 503 Pty. Ltd., Cardinal Health Austria 504 GmbH, Cardinal Health Belgium 505 BVBA, Cardinal Health Canada Holdings Cooperative U.A., Cardinal Health Canada Inc., Cardinal Health Chile Limitada, Cardinal Health Colombia S.A.S., Cardinal Health D.R. 203 II Ltd., Cardinal Health Denmark ApS, Cardinal Health Finland Oy, Cardinal Health Foundation, Cardinal Health France 506 SAS, Cardinal Health Funding LLC, Cardinal Health Germany 507 GmbH, Cardinal Health Germany Manufacturing GmbH, Cardinal Health IPS LLC, Cardinal Health International India Private Limited, Cardinal Health International Philippines Inc., Cardinal Health Ireland 419 Designated Activity Company, Cardinal Health Ireland 508 Limited, Cardinal Health Ireland Unlimited Company, Cardinal Health Italy 509 Srl, Cardinal Health Japan G.K., Cardinal Health K.K., Cardinal Health Korea Limited, Cardinal Health Malaysia 211 Sdn. Bhd., Cardinal Health Malta 212 Limited, Cardinal Health Managed Care Services LLC, Cardinal Health Medical Equipment Consulting (Shanghai) Co. Ltd., Cardinal Health Mexico 514 S. de R.L. de C.V., Cardinal Health Middle East FZ-LLC, Cardinal Health Netherlands 502 B.V., Cardinal Health P.R. 120 Inc., Cardinal Health P.R. 218 Inc., Cardinal Health P.R. 220 LLC, Cardinal Health Pharmaceutical Contracting LLC, Cardinal Health Pharmacy Services LLC, Cardinal Health Singapore 225 Pte. Ltd., Cardinal Health Spain 511 S.L., Cardinal Health Sweden 512 A.B., Cardinal Health Switzerland 515 GmbH, Cardinal Health Systems Inc., Cardinal Health Technologies LLC, Cardinal Health Technologies Switzerland GmbH, Cardinal Health U.K. 432 Limited, Cardinal Health do Brasil Ltd., CareFusion, Cirpro de Delicias S.A. de C.V., Convertors de Mexico S.A. de C.V., Cordis, Cordis (Shanghai) Medical Devices Co. Ltd., Cordis Corporation, Cornerstone Rheumatology L.P., Covidien Manufacturing Solutions S.A., Denver Biomedical, Dik Drug, EPIC Insurance Company, Emerge Medical, Enturia, Especialidades Medicas Kenmex S.A. de C.V., Futuremed Health Care Products, Gala Biotech, Geodax Technology, GetOutcomes LLC, Griffin Capital LLC, HLS Freight Services, Healthcare Solutions Holding, Innovative Therapies LLC, Instant Diagnostic Systems Inc., KPR Australia Pty. Ltd., KPR U.S. LLC, Kendall-Gammatron Limited, Kinray, Leader Drugstores Inc., Ludlow Technical Products Canada Ltd., MCD, Magellan Laboratories, Marin Apothecaries, MedMined, Medicine Shoppe International Inc., Medicine Shoppe International Inc., Mediquip Sdn. Bhd., Mirixa Corporation, Mirixa Corporation, MosaicGPO LLC, Mscripts, NaviHealth, One Cloverleaf LLC, Outcomes Incorporated, Outcomes Incorporated, Owen Healthcare, PCI Pharma Services, ParMed Pharmaceuticals, Patient Recovery Business of Medtronic, Pinnacle Intellectual Property Services Inc., Pinnacle Intellectual Property Services-International Inc., Pyxis Corporation, Quiroproductos de Cuauhtemoc S. de R.L. de C.V., R.P. Scherer Corporation, RGH Enterprises LLC, RainTree GPO LLC, RainTree Oncology Services, Renal Purchasing Group LLC, Rxealtime Inc., Sonexus Health LLC, Syncor International, TelePharm, TelePharm LLC, The Harvard Drug Group, The Harvard Drug Group L.L.C., Traverse GPO LLC, Viasys Healthcare, WaveMark Inc., Zuellig Pharma China, and mscripts LLC.
Read More
This page (NYSE:CAH) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners